Results 21 to 30 of about 831,573 (301)

Generation of B-cell-based cellular vaccine for cancer in murine models

open access: yesSTAR Protocols, 2023
Summary: A B-cell-based cellular vaccine (BVax), produced from 4-1BBL+ B cells, can select tumor-specific B cells that, upon ex vivo culture, can generate tumor-specific antibodies and activate T cells.
David Hou   +2 more
doaj   +1 more source

Current Limitations of Intraoperative Ultrasound in Brain Tumor Surgery

open access: yesFrontiers in Oncology, 2021
While benefits of intraoperative ultrasound (IOUS) have been frequently described, data on IOUS limitations are relatively sparse. Suboptimal ultrasound imaging of some pathologies, various types of ultrasound artifacts, challenging patient positioning ...
A. Šteňo   +5 more
semanticscholar   +1 more source

Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy

open access: yesCells, 2021
Despite the important evolution of immunotherapeutic agents, brain tumors remain, in general, refractory to immune therapeutics. Recent discoveries have revealed that the glioma microenvironment includes a wide variety of immune cells in various states ...
Hinda Najem   +2 more
doaj   +1 more source

Induction and Characterization of Human Glioma Clones With Different Radiosensitivities

open access: yesNeoplasia: An International Journal for Oncology Research, 1999
To facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we have generated a set of clones with different radiosensitivities from a human glioma cell line U-251 MG-Ho.
Jingli Wang   +7 more
doaj   +1 more source

Surgical Management of Giant Prolactinomas: A Descriptive Study

open access: yesInternational Journal of Endocrinology, 2023
Introduction. Giant prolactinoma (GP) is a rare pituitary lactotropic cell tumor larger than 4 cm in its widest dimension, and is less likely than a smaller prolactinoma to achieve prolactin normalization on dopamine agonist (DA) monotherapy.
Michelle D. Lundholm   +5 more
doaj   +1 more source

MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells

open access: yesStem Cell Research, 2015
Neural stem cell (NSC)-based carriers have been presented as promising therapeutic tools for the treatment of infiltrative brain tumors due to their intrinsic tumor homing property.
Nikita G. Alexiades   +11 more
doaj   +1 more source

Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas

open access: yesNature Communications, 2023
Hedgehog signaling mediates embryologic development of the central nervous system and other tissues and is frequently hijacked by neoplasia to facilitate uncontrolled cellular proliferation.
Mark W. Youngblood   +36 more
doaj   +1 more source

History of brain tumor surgery – A global and Indian perspective

open access: yesArchives of Medicine and Health Sciences, 2021
Brain tumor surgery has grown exponentially in the last century, aided by sophistication, globalization, and training initiatives. With progress in cerebral localization, antisepsis, anesthesia, and hemostasis, brain surgery took off in a cautious manner
P Shah Shreykumar   +4 more
doaj   +1 more source

Detection of Hypoxia in Human Brain Tumor Xenografts Using a Modified Comet Assay

open access: yesNeoplasia: An International Journal for Oncology Research, 2003
We used the standard comet assay successfully to generate in vitro dose-response curves under oxic and hypoxic conditions. We then made mixtures of cells that had been irradiated with 3 and 9 Gy of X-rays to simulate two subpopulations in a tumor, but ...
Jingli Wang   +8 more
doaj   +1 more source

The Neurofibromatosis 2 Tumor Suppressor Gene Product, Merlin, Regulates Human Meningioma Cell Growth by Signaling through YAP

open access: yesNeoplasia: An International Journal for Oncology Research, 2008
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder characterized by the occurrence of schwannomas and meningiomas. Several studies have examined the ability of the NF2 gene product, merlin, to function as a tumor suppressor in diverse cell ...
Katherine Striedinger   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy